Dyne Therapeutics, Inc. (DYN)

Last Three Months

19-Feb-24 -- 18-May-24

Time Period:

Three Months
|
Year

0 Net Amount

Buy:	0	--
Sell:	0	--

Company Sentiment

Other

Other

Sentiment Breakdown by Insider

0

(3)

0

(2)

4

(1)

18

0

1

+1

0

+2

0

+3

Two Year Chart

19-May-22 -- 18-May-24

Price ($)

Two Year Stock Price Chart

Sentiment

Buy & Sell Volume ($)

Two Year Insider Trading Volume Chart

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
28-Feb-24 7:13 PM View:	28-Feb-24 Sale (Planned) ($900.23K)	Atlas Venture Fund Xi, L.P. 10% Owner		Dyne Therapeutics, Inc. - DYN	15% 6.99M to 8.05M	0	0	--	--	Show Txns Hide Txns

Yesterday 9:05 PM View:	16-May-24 Private Sale (Planned) ($77.40K)	High Susanna Gatti Chief Operating Officer		Dyne Therapeutics, Inc. - DYN	(18%) 187.88K to 154.06K	0	0	--	--	Show Txns Hide Txns

05-Mar-24 5:08 PM View:	01-Mar-24 Private Sale (Planned) ($1.40M)	Rhodes Jason P Director		Dyne Therapeutics, Inc. - DYN	(16%) 9.53M to 8.0M	0	0	--	--	Show Txns Hide Txns

Yesterday 9:06 PM View:	16-May-24 Private Sale (Planned) ($67.31K)	Farwell Wildon Chief Medical Officer		Dyne Therapeutics, Inc. - DYN	(9%) 163.5K to 148.18K	0	0	--	--	Show Txns Hide Txns

Yesterday 9:07 PM View:	16-May-24 Private Sale (Planned) ($76.47K)	Beskrovnaya Oxana Chief Scientific Officer		Dyne Therapeutics, Inc. - DYN	(5%) 156.81K to 149.65K	0	0	--	--	Show Txns Hide Txns

Yesterday 9:03 PM View:	16-May-24 Private Sale (Planned) ($78.42K)	McNeill Jonathan Chief Business Officer		Dyne Therapeutics, Inc. - DYN	(5%) 143.62K to 136.63K	0	0	--	--	Show Txns Hide Txns

Yesterday 9:04 PM View:	16-May-24 Private Sale (Planned) ($73.16K)	Scalzo Richard William SVP, Head of Finance & Admin.		Dyne Therapeutics, Inc. - DYN	(6%) 124.23K to 116.69K	0	0	--	--	Show Txns Hide Txns

12-Mar-24 9:56 PM View:	11-Mar-24 Sale (Planned) ($202.93K)	Brumm Joshua T CEO & President Director		Dyne Therapeutics, Inc. - DYN	(5%) 563.47K to 538.0K	0	0	--	--	Show Txns Hide Txns

05-Mar-24 5:07 PM View:	01-Mar-24 Sale (Planned) ($513.82K)	Atlas Venture Opportunity F... 10% Owner		Dyne Therapeutics, Inc. - DYN	(2%) 2.35M to 2.31M	0	0	--	--	Show Txns Hide Txns